Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012100 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Mariska van Huizen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, Netherlands. Hauptthemen laut MEDLINE: Coronavirus Papain-Like Proteases, COVID-19. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation program, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, HORIZON EUROPE European Research Council.
Abstract (Originalsprache)
The coronavirus papain-like protease (PLpro) is crucial for viral replicase polyprotein processing. Additionally, PLpro can subvert host defense mechanisms by its deubiquitinating (DUB) and deISGylating activities. To elucidate the role of these activities during SARS-CoV-2 infection, we introduced mutations that disrupt binding of PLpro to ubiquitin or ISG15. We identified several mutations that strongly reduced DUB activity of PLpro, without affecting viral polyprotein processing. In contrast, mutations that abrogated deISGylating activity also hampered viral polyprotein processing and when introduced into the virus these mutants were not viable. SARS-CoV-2 mutants exhibiting reduced DUB activity elicited a stronger interferon response in human lung cells. In a mouse model of severe disease, disruption of PLpro DUB activity did not affect lethality, virus replication, or innate immune responses in the lungs. This suggests that the DUB activity of SARS-CoV-2 PLpro is dispensable for virus replication and does not affect innate immune responses in vivo . Interestingly, the DUB mutant of SARS-CoV replicated to slightly lower titers in mice and elicited a diminished immune response early in infection, although lethality was unaffected. We previously showed that a MERS-CoV mutant deficient in DUB and deISGylating activity was strongly attenuated in mice. Here, we demonstrate that the role of PLpro DUB activity during infection can vary considerably between highly pathogenic coronaviruses. Therefore, careful considerations should be taken when developing pan-coronavirus antiviral strategies targeting PLpro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Virology Laboratory, Leiden University Center of Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, Netherlands.
- Department of Cell and Chemical Biology, Division of Chemical Biology and Drug Discovery, Leiden University Medical Centre, Leiden, The Netherlands.
- Department of Microbiology, University of Manitoba, Winnipeg, Canada.
ORCID-Profile: Mariska van Huizen, Eric J Snijder, Marjolein Kikkert
Förderung
- European Union’s Horizon 2020 research and innovation program
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- HORIZON EUROPE European Research Council
Zitieren
APA
van Huizen, M., Bloeme-Ter Horst, J. R., de Gruyter, H. L. M., Geurink, P. P., van der Heden van Noort, G. J., Knaap, R. C. M., Nelemans, T., Ogando, N. S., Leijs, A. A., Urakova, N., Mark, B. L., Snijder, E. J., Myeni, S. K., & Kikkert, M. (2024). Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012100
Vancouver
van Huizen M, Bloeme-Ter Horst JR, de Gruyter HLM, Geurink PP, van der Heden van Noort GJ, Knaap RCM, et al. Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012100
BibTeX
@article{vanHuizen2024,
author = {van Huizen, Mariska and Bloeme-Ter Horst, Jonna R and de Gruyter, Heidi L M and Geurink, Paul P and van der Heden van Noort, Gerbrand J and Knaap, Robert C M and Nelemans, Tessa and Ogando, Natacha S and Leijs, Anouk A and Urakova, Nadya and Mark, Brian L and Snijder, Eric J and Myeni, Sebenzile K and Kikkert, Marjolein},
title = {Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012100}
}
EUVIMED